SIRT7 activity displays a crucial role in prostate cancer where its depletion in vitro and in vivo causes inhibition of cell proliferation, autophagy and invasion via the downregulation of androgen receptor (AR) pathway mediated by small mother against the decapentaplegic 4 (SMAD4) protein [67]. Here, AR is linked to prostate carcinoma.